Brief: Stenocare Signs Supply Agreement With Emerald Health Therapeutics

StenoCare A/S

07/11/2019 12:05

Nov 7 (Reuters) - StenoCare A/S  STENO.TE :
    * STENOCARE SIGN SUPPLY AGREEMENT WITH EMERALD HEALTH
THERAPEUTICS
INC
    * OBJECTIVE IS TO PARTNER WITH MORE THAN ONE SUPPLIER TO
SECURE
FUTURE PRODUCT SUPPLY SITUATION AND THEREBY OFFER PATIENTS AND
PHYSICIANS MORE CHOICE FOR THEIR TREATMENT
    * AFTER SIGNING OF AGREEMENT, STENOCARE AND EMERALD WILL
IMMEDIATELY COMMENCE WORK WITH DMA TO HAVE PRODUCTS READY AND
APPROVED FOR DANISH MEDICAL CANNABIS PILOT PROGRAMME
    * COMPANIES ARE AIMING FOR PRODUCT APPROVAL FOR CBD OIL, THC
OIL
AND CBD+THC OIL
    * PARTNERSHIP IS ALSO INTENDED TO EXTEND TO STENOCARE'S
IRISH
SUBSIDIARY AND TO ADDITIONAL MARKETS WHICH ARE BEING EVALUATED

Source text for Eikon:  ID:nWkrWSj4h 
Further company coverage:  STENO.TE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587785110;))